Avinasi Labs Enables a New Funding & Revenue Model for Clinical Stage Assets via DeLong Protocol SAN FRANCISCO, CA, UNITED STATES, December 31, 2025 /EINPresswire.com/ — Avinasi Labs, an AI-native ...
In the realm of modern medicine, RNA-based therapies have emerged as a promising avenue, with significant advancements in metabolic diseases, oncology, and preventive vaccines. A recent article ...
Discover how AI is revolutionizing RNA drug development in a new article published in Engineering. Learn about the potential ...
In the pharmaceutical discovery process, understanding a drug’s residence time—the duration a molecule remains bound to its ...
Insilico Medicine (3696.HK), a clinical-stage drug discovery and development company driven by generative artificial ...
Artificial intelligence (AI) is revolutionising the field of drug discovery and disease modelling, with a significant impact ...
Discover how drugs prevent, cure, and alleviate ailments. Learn about over-the-counter vs. prescription drugs and the pharmaceutical industry's impact on healthcare.
In 2001, chemists K. Barry Sharpless, Hartmuth C. Kolb, and M. G. Finn introduced click chemistry, a concept in which organic ...
Hosted on MSN
Scientist breaks major barrier for AI drug research
A scientist is addressing a critical roadblock in applying AI to drug discovery, marking a potential breakthrough in the field. On October 17, 2025, reports emerged of a new model designed to boost ...
Artificial intelligence and machine learning are being embedded in every aspect of the drug discovery and development process. In the preclinical stages, for example, companies are using advanced AI ...
Cambridge, MA – October 3, 2025 – Insilico Medicine (“Insilico”), a clinical-stage biotechnology company driven by generative artificial intelligence (AI), today announced the release of a major ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback